Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
We employ advanced molecular techniques, specifically polymerase chain reaction (PCR) testing, for identifying microbes in various specimen types.
PCR microbe identification is combined with our phenotypic antibiotic susceptibility testing.
Our limited viral respiratory panel (LVRP) includes Influenza A, Influenza B, and RSV.
Quick pathogen identification of 7 common pathogens for sexually transmitted infections or non-gonococcal urethritis.
Our molecular diagnostic method for UTIs utilizes semi-quantitative qPCR, which targets specific pathogens and resistance genes. This includes testing for clinically relevant pathogens, multiple antibiotic resistance genes, and phenotypic molecular susceptibility to commonly utilized antibiotics.
Results are reported to healthcare providers within ~8 hours of receiving the specimen for positive or negative results, with full antibiotic susceptibility testing results available within ~30 hours for positive cases.
While genetic mutations may not always be expressed, they can become active under certain cellular conditions and emphasizes the importance of both genotypic and phenotypic antibiotic susceptibility testing. Our UTI test goes beyond just testing for antibiotic resistant genes.
Positive samples are also run on our proprietary molecular platform that determines phenotypic antibiotic susceptibility. Results are provided to physicians in less than ~30 hours.
While there is a vast amount of research on the benefits of utilizing PCR for microbe identification, this review will focus specifically on the use of PCR in detecting uropathogens.
We test for 7 common pathogens associated with sexually transmitted infections or non-gonococcal urethritis using PCR technology. This allows for rapid detection and timely results for our healthcare providers and patients.
Results are reported to healthcare providers within ~8 hours of receiving the specimen at the laboratory.
Approved specimen collection methods include urine or swab.
Our laboratory utilizes PCR technology to identify common pathogens causing respiratory illness. Specimens are ordered by a healthcare provider, collected at your facility or office, and then shipped overnight to our lab. Our limited viral respiratory pathogen panel tests both boast high sensitivity and specificity.
- Limited Viral Respiratory Panel (LVRP): Influenza A, Influenza B, RSV
PCR viral testing is more sensitive than rapid viral detection kits, resulting in fewer false negatives. Rapid tests typically have a lower limit of detection of 125-140 genome equivalents/mL, while PCR technology can detect infection at lower viral loads (40 genome equivalents/mL) by requiring less viral genetic material.
We offer fast turnaround time, with results for our respiratory pathogen tests available on the day of specimen arrival at the lab. Our reports include CT mean values, which can aid in evaluating viral load.
We have multiple additional tests that are in validation and will be available soon.
- Kidney Stone
- Pre-Prostsate Biopsy Rectal Swab
- PGx Testing
- Wound Care
Phone: 913.624.9005 | Fax: 913.261.9117 | 14215 Metcalf, Overland Park, Kansas 66223 | clientservices@mokanlabs.com
Copyright © 2023 Mokan Labs, LLC - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.